Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"18,034 (14,815, 21,444)","64.9% (58.5%, 71.4%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","64.9% (58.5%, 71.4%)","16.2 (14.6, 17.9)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","16.2 (14.6, 17.9)",,,,,
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.500)","13,954 (9,557, 17,558)","75.6% (68.2%, 85.3%)","22.7% (16.2%, 27.9%)","2.4% (1.8%, 3.3%)","50.5% (41.6%, 58.0%)","18.9 (17.1, 21.3)","5.7 (4.1, 7.0)","0.6 (0.4, 0.8)","12.6 (10.4, 14.5)","-22.9% (-39.9%, -14.0%)","16.5% (10.4%, 30.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-22.3% (-30.2%, -13.8%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.750)","13,900 (9,162, 18,731)","76.1% (66.4%, 87.1%)","33.8% (23.1%, 41.8%)","3.5% (2.4%, 4.9%)","38.8% (28.6%, 49.4%)","19.0 (16.6, 21.8)","8.5 (5.8, 10.5)","0.9 (0.6, 1.2)","9.7 (7.2, 12.3)","-23.2% (-42.3%, -7.4%)","17.4% (7.6%, 33.4%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-40.3% (-53.3%, -29.1%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=1.000)","14,113 (9,037, 17,761)","76.3% (68.4%, 89.9%)","44.7% (31.3%, 57.1%)","4.5% (3.3%, 6.5%)","27.1% (14.1%, 39.4%)","19.1 (17.1, 22.5)","11.2 (7.8, 14.3)","1.1 (0.8, 1.6)","6.8 (3.5, 9.9)","-21.9% (-45.6%, -11.9%)","17.6% (10.1%, 37.0%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-58.4% (-77.3%, -40.1%)"
